Spain - Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use
Since 2014, Spain Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use increased 0.6% year on year. At 128.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was ranked number 2 among other countries in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use. Netherlands lead the ranking with 131.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, a growth of 3.9% versus 2018. Canada witnessed the best average annual growth at +11.3% per year, while Austria recorded the worst performance at -14% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 128.80 |
| 2018 | 125.30 |
| 2017 | 123.30 |
| 2016 | 125.60 |
| 2015 | 124.80 |
Download all data from 1992 to 2019
How does Spain rank in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
Netherlands
|
132 | 2019 | +3.9 % | +3.5 % | View data |
| 2 |
#2
Spain
|
129 | 2019 | +2.8 % | +0.6 % | View data |
| 3 |
#3
United Kingdom
|
116 | 2019 | +3.1 % | +3.4 % | View data |
| 4 |
#4
Iceland
|
110 | 2019 | +2.3 % | +4.8 % | View data |
| 5 |
#5
Portugal
|
103 | 2019 | +10.5 % | +2.2 % | View data |